The Impact of Onset to Hospital Admission Time on Clinical Outcome in Patients with Ischemic Stroke without Reperfusion Therapy
DOI:
https://doi.org/10.24079/cajms.2018.12.008Keywords:
Stroke, Hospital Admission Time, Treatment Outcome, IndonesiaAbstract
Objective: The narrow therapeutic window after stroke onset is a major concern in stroke treatment, especially in developing countries. This study aimed to investigate the correlation between onset to hospital admission time and clinical outcome in patients with ischemic stroke who did not receive reperfusion therapy. Method: A total of 313 patients with ischemic stroke were recruited in this retrospective cohort study. Data were obtained from the electronic stroke registry of Bethesda Hospital Yogyakarta, Indonesia. Ischemic stroke was diagnosed by well-trained neurologists and confirmed by brain CT-scan. Clinical outcome was assessed using the modified Rankin scale. Predictors of clinical outcome were assessed. Data analysis was conducted using multiple logistic regression. Results: The incidence of disability and death were 30.4% (95/313) and 7.6% (24/313) respectively. Multiple logistic regression analysis showed onset to hospital admission time greater than 6 hours (OR: 4.56; 95% CI:2.372- 8.792; p<.001 was an independent factor to a significant increase in disability risk. However, longer onset to hospital admission time did not significantly increase the risk of death. Age and complications were independent predictive factors of both disability (OR: 2.36; 95% CI:1.357- 4.125; p=.002 and OR: 12.4; 95% CI:2.443-62.968; p=.002, respectively) and mortality (OR: 3.66; 95% CI:1.147-11.711; p=.028 and OR: 58.8; 95% CI:10.353-333.983; p<.001, respectively). Conclusion: Shorter onset to hospital admission time could save ischemic stroke patients from disability.
Downloads
59
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Mongolian National University of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.